GENB insider buying
1 cluster buyGenerate Biomedicines, Inc. · Healthcare
When two or more insiders at Generate Biomedicines, Inc. buy GENB on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in GENB plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Mar 2 – Mar 4, 2026Detected Mar 4, 2026High conviction3 insidersTotal bought$150.2MMarket cap$2.2B
All notable open-market buys in GENB
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Mar 4, 2026 | Nally Michaelcluster Director, Chief Executive Officer | 20,000 | $12.00 | $240.0K | SEC ↗ |
| Mar 2, 2026 | 10% Owner | 1,562,500 | $16.00 | $25.0M | SEC ↗ |
| Mar 2, 2026 | 10% Owner | 1,562,500 | $16.00 | $25.0M | SEC ↗ |
| Mar 2, 2026 | 10% Owner | 1,562,500 | $16.00 | $25.0M | SEC ↗ |
| Mar 2, 2026 | 10% Owner | 1,562,500 | $16.00 | $25.0M | SEC ↗ |
| Mar 2, 2026 | 10% Owner | 1,562,500 | $16.00 | $25.0M | SEC ↗ |
| Mar 2, 2026 | 10% Owner | 1,562,500 | $16.00 | $25.0M | SEC ↗ |
| Mar 2, 2026 | Director | 1,500 | $16.00 | $24.0K | SEC ↗ |
| Mar 2, 2026 | President & CFO | 1,000 | $16.00 | $16.0K | SEC ↗ |
| Mar 2, 2026 | President & CFO | 500 | $16.00 | $8.0K | SEC ↗ |
| Mar 2, 2026 | President & CFO | 500 | $16.00 | $8.0K | SEC ↗ |
| Mar 2, 2026 | Chief People Officer | 300 | $16.00 | $4.8K | SEC ↗ |
More Healthcare stocks with insider cluster buys
GENB insider buying — FAQ
- Are insiders buying GENB stock?
- Yes — 6 distinct insiders have bought GENB (Generate Biomedicines, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Mar 6, 2026.
- How much GENB stock have insiders bought?
- Insiders have bought a combined $150.3M of GENB across 12 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in GENB?
- A cluster buy is two or more distinct Generate Biomedicines, Inc. insiders — officers, directors, or 10% owners — each buying GENB on the open market within a rolling window. GENB has 1 detected cluster buy to date.
- Where does this GENB insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in GENB
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy GENB within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding GENB.